Patents by Inventor Ramakrishna Nallamothu

Ramakrishna Nallamothu has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Levothyroxine formulation with acacia
    Patent number: 9271951
    Abstract: A pharmaceutical composition comprising thyroxine, acacia, and an antioxidant selected from propyl gallate, butylated hydroxyanisol, and butylated hydroxytoluene is disclosed. The pharmaceutical composition has an improved shelf life. In one embodiment, the composition additionally comprises sucrose, microcrystalline cellulose, and mannitol. The pharmaceutical composition may be used for treating thyroid disorders by orally administering the composition to a patient in need thereof.
    Type: Grant
    Filed: December 21, 2012
    Date of Patent: March 1, 2016
    Assignee: Mylan Inc.
    Inventors: John Kirsch, Ramakrishna Nallamothu, Baris E. Polat
  • LEVOTHYROXINE FORMULATION WITH CARRAGEENAN
    Publication number: 20140179784
    Abstract: A pharmaceutical composition comprising thyroxine and carrageenan. The pharmaceutical composition has an improved shelf life compared to other pharmaceutical compositions containing thyroxine. In one embodiment, the composition additionally comprises sucrose, microcrystalline cellulose, and mannitol. The pharmaceutical composition may be used for treating thyroid disorders by orally administering the composition to a patient in need thereof.
    Type: Application
    Filed: December 21, 2012
    Publication date: June 26, 2014
    Applicant: Mylan Inc.
    Inventors: John Kirsch, Ramakrishna Nallamothu, Baris E. Polat
  • LEVOTHYROXINE FORMULATION WITH ACACIA
    Publication number: 20140178511
    Abstract: A pharmaceutical composition comprising thyroxine, acacia, and an antioxidant selected from propyl gallate, butylated hydroxyanisol, and butylated hydroxytoluene is disclosed. The pharmaceutical composition has an improved shelf life. In one embodiment, the composition additionally comprises sucrose, microcrystalline cellulose, and mannitol. The pharmaceutical composition may be used for treating thyroid disorders by orally administering the composition to a patient in need thereof.
    Type: Application
    Filed: December 21, 2012
    Publication date: June 26, 2014
    Applicant: Mylan Inc.
    Inventors: John Kirsch, Ramakrishna Nallamothu, Baris E. Polat